ChartMill assigns a Buy % Consensus number of 84% to CNTX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-09-18 | Guggenheim | Initiate | Buy |
| 2025-08-07 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-26 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-05-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-21 | William Blair | Initiate | Outperform |
| 2025-04-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-08 | JMP Securities | Initiate | Market Outperform |
| 2024-11-25 | D. Boral Capital | Initiate | Buy |
| 2024-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | Piper Sandler | Initiate | Overweight |
| 2024-05-09 | Maxim Group | Maintains | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-01 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2023-09-11 | Maxim Group | Initiate | Buy |
| 2023-06-06 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-03-23 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-02-07 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-02-02 | HC Wainwright & Co. | Initiate | Buy |
14 analysts have analysed CNTX and the average price target is 5.44 USD. This implies a price increase of 418.09% is expected in the next year compared to the current price of 1.05.
The consensus rating for CONTEXT THERAPEUTICS INC (CNTX) is 84.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.